ERD

Survival in Kidney and Bladder Cancers in Four Nordic Countries through a Half Century

Project: Chaperon

Updated at: 01-11-2024

Show more information

Project acronym Chaperon

Steady survival improvements in soft tissue and bone sarcoma in the Nordic countries through 50 years

Project: Chaperon

Updated at: 01-11-2024

Show more information

Project acronym Chaperon

Population-Attributable Fractions of Personal Comorbidities for Liver, Gallbladder, and Bile Duct Cancers

Project: Chaperon

Updated at: 01-11-2024

Show more information

Project acronym Chaperon

Personal comorbidities and their subsequent risks for liver, gallbladder and bile duct cancers

Project: Chaperon

Updated at: 01-11-2024

Show more information

Project acronym Chaperon

Long‐term survival trends in solid cancers in the Nordic countries marking timing of improvements

Project: Chaperon

Updated at: 01-11-2024

Show more information

Project acronym Chaperon

Theranostics Nanomedicine Applications for Colorectal Cancer and Metastasis: Recent Advances

Project: Chaperon

Updated at: 01-11-2024

Show more information

Project acronym Chaperon

Burden of malignant mesothelioma in China during 1990–2019 and the projections through 2029

Project: Chaperon

Updated at: 01-11-2024

Show more information

Project acronym Chaperon

Polymorphisms within Autophagy-Related Genes as Susceptibility Biomarkers for Multiple Myeloma: A Meta-Analysis of Three...

Project: Chaperon

Updated at: 01-11-2024

Show more information

Project acronym Chaperon

Long-Term Periodic and Conditional Survival Trends in Prostate, Testicular, and Penile Cancers in the Nordic Countries, ...

Project: Chaperon

Updated at: 01-11-2024

Show more information

Project acronym Chaperon

Age-specific survival in acute myeloid leukemia in the Nordic countries through a half century

Project: Chaperon

Updated at: 01-11-2024

Show more information

Project acronym Chaperon

Major improvement in thyroid cancer survival of elderly patients in the Nordic countries

Project: Chaperon

Updated at: 01-11-2024

Show more information

Project acronym Chaperon

Long-term survival trends for primary liver and pancreatic cancers in the Nordic countries

Project: Chaperon

Updated at: 01-11-2024

Show more information

Project acronym Chaperon

A metric for comparison and visualization of age disparities in cancer survival

Project: Chaperon

Updated at: 01-11-2024

Show more information

Project acronym Chaperon

Large differencies in age-specific survival in multiple myeloma in the nordic countries

Project: Chaperon

Updated at: 01-11-2024

Show more information

Project acronym Chaperon

Survival in Elderly Ovarian Cancer Remains Challenging in the Nordic Countries

Project: Chaperon

Updated at: 01-11-2024

Show more information

Project acronym Chaperon

CTNNB1 mutations, TERT polymorphism and CD8+ cell densities in resected hepatocellular carcinoma are associated with lon...

Project: Chaperon

Updated at: 01-11-2024

Show more information

Project acronym Chaperon

Survival in hematological malignancies in the Nordic countries through a half century with correlation to treatment

Project: Chaperon

Updated at: 01-11-2024

Show more information

Project acronym Chaperon

Conditional survival in breast cancer up to 10 years in the Nordic countries

Project: Chaperon

Updated at: 01-11-2024

Show more information

Project acronym Chaperon

Conditional Survival in Prostate Cancer in the Nordic Countries Elucidates the Timing of Improvements

Project: Chaperon

Updated at: 01-11-2024

Show more information

Project acronym Chaperon

Survival improvements in esophageal and gastric cancers in the Nordic countries favor younger patients

Project: Chaperon

Updated at: 01-11-2024

Show more information

Project acronym Chaperon

Monitoring of telomere dynamics in peripheral blood leukocytes in relation to colorectal cancer patients’ outcomes

Project: Chaperon

Updated at: 01-11-2024

Show more information

Project acronym Chaperon

Activated Hepatic Stellate Cells in Hepatocellular Carcinoma: Their Role as a Potential Target for Future Therapies

Project: Chaperon

Updated at: 01-11-2024

Show more information

Project acronym Chaperon

Survival in melanoma in the nordic countries into the era of targeted and immunological therapies

Project: Chaperon

Updated at: 01-11-2024

Show more information

Project acronym Chaperon

Prognostic role of macrophages and mast cells in the microenvironment of hepatocellular carcinoma after resection

Project: Chaperon

Updated at: 01-11-2024

Show more information

Project acronym Chaperon

Identification of novel genetic loci for risk of multiple myeloma by functional annotation

Project: Chaperon

Updated at: 01-11-2024

Show more information

Project acronym Chaperon

Autoimmune diseases as comorbidities for liver, gallbladder, and biliary duct cancers in Sweden

Project: Chaperon

Updated at: 01-11-2024

Show more information

Project acronym Chaperon

Early mortality critically impedes improvements in thyroid cancer survival through a half century

Project: Chaperon

Updated at: 01-11-2024

Show more information

Project acronym Chaperon

Survival trends in hematological malignancies in the Nordic countries through 50 years

Project: Chaperon

Updated at: 01-11-2024

Show more information

Project acronym Chaperon

Critical survival periods in prostate cancer in Sweden explored by conditional survival analysis

Project: Chaperon

Updated at: 01-11-2024

Show more information

Project acronym Chaperon

Survival trends in solid cancers in the Nordic countries through 50 years

Project: Chaperon

Updated at: 01-11-2024

Show more information

Project acronym Chaperon

Resources

Selected filters:

Survival in Kidney and Bladder Cancers in Four Nordic Countries through a Half Century

Steady survival improvements in soft tissue and bone sarcoma in the Nordic countries through 50 years

Population-Attributable Fractions of Personal Comorbidities for Liver, Gallbladder, and Bile Duct Cancers

Personal comorbidities and their subsequent risks for liver, gallbladder and bile duct cancers

Long‐term survival trends in solid cancers in the Nordic countries marking timing of improvements

Theranostics Nanomedicine Applications for Colorectal Cancer and Metastasis: Recent Advances

Burden of malignant mesothelioma in China during 1990–2019 and the projections through 2029

Polymorphisms within Autophagy-Related Genes as Susceptibility Biomarkers for Multiple Myeloma: A Meta-Analysis of Three...

Long-Term Periodic and Conditional Survival Trends in Prostate, Testicular, and Penile Cancers in the Nordic Countries, ...

Age-specific survival in acute myeloid leukemia in the Nordic countries through a half century

Major improvement in thyroid cancer survival of elderly patients in the Nordic countries

Long-term survival trends for primary liver and pancreatic cancers in the Nordic countries

A metric for comparison and visualization of age disparities in cancer survival

Large differencies in age-specific survival in multiple myeloma in the nordic countries

Survival in Elderly Ovarian Cancer Remains Challenging in the Nordic Countries

CTNNB1 mutations, TERT polymorphism and CD8+ cell densities in resected hepatocellular carcinoma are associated with lon...

Survival in hematological malignancies in the Nordic countries through a half century with correlation to treatment

Conditional survival in breast cancer up to 10 years in the Nordic countries

Conditional Survival in Prostate Cancer in the Nordic Countries Elucidates the Timing of Improvements

Survival improvements in esophageal and gastric cancers in the Nordic countries favor younger patients

Monitoring of telomere dynamics in peripheral blood leukocytes in relation to colorectal cancer patients’ outcomes

Activated Hepatic Stellate Cells in Hepatocellular Carcinoma: Their Role as a Potential Target for Future Therapies

Survival in melanoma in the nordic countries into the era of targeted and immunological therapies

Prognostic role of macrophages and mast cells in the microenvironment of hepatocellular carcinoma after resection

Identification of novel genetic loci for risk of multiple myeloma by functional annotation

Autoimmune diseases as comorbidities for liver, gallbladder, and biliary duct cancers in Sweden

Early mortality critically impedes improvements in thyroid cancer survival through a half century

Survival trends in hematological malignancies in the Nordic countries through 50 years

Critical survival periods in prostate cancer in Sweden explored by conditional survival analysis

Survival trends in solid cancers in the Nordic countries through 50 years